Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimiliano Mazza

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|July 13, 2013
Is PML a Tumor Suppressor?Massimiliano Mazza, Pier Giuseppe Pelicci
Breast Cancer Research and Treatment|June 13, 2023
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the countrySara Bravaccini, Massimiliano Mazza, Roberta Maltoni
Neuroendocrinology|April 16, 2025
Special Issue Advancements and Challenges in Neuroendocrine Tumor ResearchPatricia Borges de Souza, Massimiliano Mazza
International Journal of Molecular Sciences|October 16, 2025
Special Issue "The Promising Future of CAR-Based Therapies: A Matter of Molecular Details"Fabio Nicolini, Orsola Montini, Matteo Zurlo, et al.
The Journal of Biological Chemistry|September 9, 2005
Differential requirement for phospholipase D/Spo14 and its novel interactor Sma1 for regulation of exocytotic vesicle fusion in yeast meiosisChristian G Riedel, Massimiliano Mazza, Peter Maier, et al.
Cancer Letters|March 19, 2026
Can Macrophages Predict Response to Neoadjuvant Therapy in Lung Cancer? A Lesson from Breast CancerFederico Pio Fabrizio, Francesco Pegreffi, Rosario Leonardi, et al.
Translational Psychiatry|December 7, 2021
Virtual reality: a powerful technology to provide novel insight into treatment mechanisms of addictionMassimiliano Mazza, Kornelius Kammler-Sücker, Tagrid Leménager, et al.
Frontiers in Immunology|October 20, 2025
Editorial: New avenues for the development of advanced immunotherapies: capitalizing on studies of the B and T cell receptor repertoireFabio Nicolini, Mar Naranjo Gomez, Mireia Pelegrin, et al.
Cancers|April 12, 2020
Fully Human Antibodies for Malignant Pleural Mesothelioma TargetingFabio Nicolini, Martine Bocchini, Davide Angeli, et al.
Frontiers in Oncology|February 11, 2020
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the FutureFabio Nicolini, Martine Bocchini, Giuseppe Bronte, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|July 13, 2013
Is PML a Tumor Suppressor?Massimiliano Mazza, Pier Giuseppe Pelicci
Breast Cancer Research and Treatment|June 13, 2023
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the countrySara Bravaccini, Massimiliano Mazza, Roberta Maltoni
Neuroendocrinology|April 16, 2025
Special Issue Advancements and Challenges in Neuroendocrine Tumor ResearchPatricia Borges de Souza, Massimiliano Mazza
International Journal of Molecular Sciences|October 16, 2025
Special Issue "The Promising Future of CAR-Based Therapies: A Matter of Molecular Details"Fabio Nicolini, Orsola Montini, Matteo Zurlo, et al.
The Journal of Biological Chemistry|September 9, 2005
Differential requirement for phospholipase D/Spo14 and its novel interactor Sma1 for regulation of exocytotic vesicle fusion in yeast meiosisChristian G Riedel, Massimiliano Mazza, Peter Maier, et al.
Cancer Letters|March 19, 2026
Can Macrophages Predict Response to Neoadjuvant Therapy in Lung Cancer? A Lesson from Breast CancerFederico Pio Fabrizio, Francesco Pegreffi, Rosario Leonardi, et al.
Translational Psychiatry|December 7, 2021
Virtual reality: a powerful technology to provide novel insight into treatment mechanisms of addictionMassimiliano Mazza, Kornelius Kammler-Sücker, Tagrid Leménager, et al.
Frontiers in Immunology|October 20, 2025
Editorial: New avenues for the development of advanced immunotherapies: capitalizing on studies of the B and T cell receptor repertoireFabio Nicolini, Mar Naranjo Gomez, Mireia Pelegrin, et al.
Cancers|April 12, 2020
Fully Human Antibodies for Malignant Pleural Mesothelioma TargetingFabio Nicolini, Martine Bocchini, Davide Angeli, et al.
Frontiers in Oncology|February 11, 2020
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the FutureFabio Nicolini, Martine Bocchini, Giuseppe Bronte, et al.
Pageof 6